This topic contains a solution. Click here to go to the answer

Author Question: A rule that is not automatically discriminatory, but which may be discriminatory in practice because ... (Read 44 times)

Anajune7

  • Hero Member
  • *****
  • Posts: 574
A rule that is not automatically discriminatory, but which may be discriminatory in practice because it excludes too many people in a protected group is considered
 A)disparate treatment.
 B)prima facie discrimination.
 C)unbalanced treatment.
 D)disparate impact.

Question 2

Which of the following is one of the President's inherent powers?
 A) The power to conduct foreign affairs
 B) The power to appoint and receive foreign ambassadors
 C) The power to act as commander-in-chief of the armed forces
 D) All of the above



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Kimmy

  • Sr. Member
  • ****
  • Posts: 342
Answer to Question 1

D

Answer to Question 2

D




Anajune7

  • Member
  • Posts: 574
Reply 2 on: Jun 24, 2018
Excellent


Dnite

  • Member
  • Posts: 297
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

A strange skin disease referred to as Morgellons has occurred in the southern United States and in California. Symptoms include slowly healing sores, joint pain, persistent fatigue, and a sensation of things crawling through the skin. Another symptom is strange-looking, threadlike extrusions coming out of the skin.

Did you know?

Elderly adults are living longer, and causes of death are shifting. At the same time, autopsy rates are at or near their lowest in history.

Did you know?

Aspirin may benefit 11 different cancers, including those of the colon, pancreas, lungs, prostate, breasts, and leukemia.

Did you know?

Only one in 10 cancer deaths is caused by the primary tumor. The vast majority of cancer mortality is caused by cells breaking away from the main tumor and metastasizing to other parts of the body, such as the brain, bones, or liver.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library